Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.610
-0.050 (-1.88%)
At close: Nov 21, 2024, 4:00 PM
2.550
-0.060 (-2.30%)
After-hours: Nov 21, 2024, 5:16 PM EST

Aerovate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
75626721288--
Market Cap Growth
-83.92%-13.15%150.50%---
Enterprise Value
-13492580108--
Last Close Price
2.6122.6329.3011.79--
PB Ratio
0.945.725.691.67--
P/TBV Ratio
0.755.725.691.67--
Debt / Equity Ratio
0.010.010.010.00-7.00
Quick Ratio
8.606.9416.6065.642.585.35
Current Ratio
8.787.0416.9068.372.645.35
Return on Equity (ROE)
-82.06%-63.95%-34.44%-26.19%-582.84%-
Return on Assets (ROA)
-48.67%-38.73%-21.42%-15.98%-135.03%-
Return on Capital (ROIC)
-54.36%-42.76%-22.12%-16.36%-191.64%-
Earnings Yield
-112.27%-12.06%-7.15%-7.98%--
FCF Yield
-99.54%-9.09%-5.45%-9.58%--
Buyback Yield / Dilution
-10.95%-7.60%-99.06%-4975.15%-0.32%-
Total Shareholder Return
-10.95%-7.60%-99.06%-4975.15%-0.32%-
Source: S&P Capital IQ. Standard template. Financial Sources.